Relay Therapeutics, Inc. (RLAY)
NASDAQ: RLAY · Real-Time Price · USD
4.655
-0.005 (-0.11%)
Nov 21, 2024, 2:34 PM EST - Market open
Relay Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
Nov '24 Nov 21, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Market Capitalization | 778 | 1,357 | 1,806 | 3,318 | 3,733 | - | |
Market Cap Growth | 11.98% | -24.86% | -45.57% | -11.11% | - | - | |
Enterprise Value | -10 | 601 | 813 | 2,725 | 3,043 | - | |
Last Close Price | 4.66 | 11.01 | 14.94 | 30.71 | 41.56 | - | |
PS Ratio | 61.56 | 53.13 | 1307.87 | 1095.42 | 45.16 | - | |
PB Ratio | 0.93 | 1.80 | 1.90 | 3.70 | 4.89 | - | |
P/TBV Ratio | 1.37 | 1.81 | 1.91 | 3.71 | 4.89 | - | |
EV/Sales Ratio | 51.26 | 23.53 | 588.46 | 899.58 | 36.82 | - | |
Debt / Equity Ratio | 0.06 | 0.07 | 0.06 | 0.03 | 0.03 | 0.07 | |
Asset Turnover | 0.01 | 0.03 | 0.00 | 0.00 | 0.14 | - | |
Quick Ratio | 17.88 | 24.78 | 15.76 | 39.60 | 55.80 | 29.69 | |
Current Ratio | 18.42 | 25.44 | 16.00 | 40.14 | 56.49 | 30.08 | |
Return on Equity (ROE) | -42.69% | -40.18% | -31.44% | -43.81% | -9.35% | -19.35% | |
Return on Assets (ROA) | -26.87% | -24.40% | -18.44% | -15.63% | -5.85% | -12.79% | |
Return on Capital (ROIC) | -28.68% | -26.15% | -20.15% | -16.54% | -5.96% | -13.07% | |
Earnings Yield | -45.03% | -25.20% | -16.08% | -10.97% | -1.40% | - | |
FCF Yield | -36.86% | -22.43% | -13.21% | -2.35% | -2.80% | - | |
Buyback Yield / Dilution | -8.66% | -9.22% | -17.97% | -123.22% | -1135.17% | -38.84% | |
Total Shareholder Return | -8.66% | -9.22% | -17.97% | -123.22% | -1135.17% | -38.84% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.